Investigating the role of DNA repair mechanisms in the development of age-related podocyte malfunction and its consequence on key organs
Investigating the role of DNA repair mechanisms in the development of age-related podocyte malfunction and its consequence on key organs
批准号:
436848806
负责人:
Professor Dr. Tobias B. Huber
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
For decades, clinicians have recognised that the kidney loses function with age. The elderly exhibit progressive decreases in renal blood flow and glomerular filtration rate. As ageing is a systemic event, affecting all organs, it is difficult to resolve between intrinsic age-related (whose that originate within the kidney) and extrinsic events which are responsible for the loss of renal function. Being able to resolve this issue is key to firstly developing a fully mechanistic understanding of the ageing process in the kidney and secondly developing therapies aimed at improving the quality of patient life.Accumulation of DNA damage is one of the key drivers underpinning age-related organ function decline. We have shown that loss-of-function mutations in key regulator of DNA repair (Excision repair cross-complementation 1, Ercc1) lead to progeria (accelerated ageing) which manifests in loss of kidney function. Recently, we have made the striking finding that attenuation of Activin receptor signalling (using the soluble ligand trap protein sActRIIB) prevented many of the key signs of ageing including preventing proteinuria, maintenance of normal podocyte food processes and glomerular basement membrane morphology. Our findings embody an extraordinary prospect to not only identify the signalling pathway the underpin that age-related decline in kidney function but more notably establish a means of discovering pathways and ultimately the molecules that can prevent renal pathology. In this ground-breaking project, we hypothesise that: The accumulation of DNA mutations in podocytes leads to aberrant Activin signalling that attenuates kidney function and initiates a cascade of inter-organ signalling that leads to systemic perturbations. The aims will be reached using a multidisciplinary approach encompassing tissue, cellular and molecular approaches guided by cutting-edge bio-informatic tools. It is our goal that by the end of the project we will not only develop mechanistic insight into the processes that lead to age-related kidney malfunction but also to identify therapeutic targets as a treatment option.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of the podocyte actin network
-
批准号:241702976
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Professor Dr. Tobias B. Huber
-
依托单位:
Chronische Nierenerkrankungen und Altersforschung
-
批准号:237791083
-
项目类别:Heisenberg Professorships
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Professor Dr. Tobias B. Huber
-
依托单位:
Center for Glomerular Disease and Aging (CGDA)
-
批准号:208202502
-
项目类别:Heisenberg Fellowships
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Professor Dr. Tobias B. Huber
-
依托单位:
The Role of mTOR dependent and independent signalling pathways for renal tubular cystogenesis
-
批准号:77902956
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Professor Dr. Tobias B. Huber
-
依托单位:
Dynamische Podozytenfunktion zur Regulation des Nierenfilters
-
批准号:26722853
-
项目类别:Independent Junior Research Groups
-
资助金额:$0.0万
-
财政年份:2006
-
负责人:Professor Dr. Tobias B. Huber
-
依托单位:
Mechanismen dynamischer Schlitzmembranfunktionen
-
批准号:5419511
-
项目类别:Emmy Noether International Fellowships
-
资助金额:$0.0万
-
财政年份:2003
-
负责人:Professor Dr. Tobias B. Huber
-
依托单位:
Predictors of Somatic Symptom Persistence in Patients With Chronic Kidney Disease (RU SOMACROSS)
-
批准号:460374559
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Tobias B. Huber
-
依托单位:
Combined high-resolution structural and functional characterization of the multi-layered bipartite NEPH-NEPHRIN based slit diaphragm
-
批准号:429077705
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Tobias B. Huber
-
依托单位:
国内基金
海外基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
-
批准号:82371070
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵培泉
-
依托单位: